New Standard of Care for Head & Neck Cancer

by | Oct 8, 2020 | Brain Cancer, CyberKnife Center of Miami, Head & Neck Cancer

Adding Radiosurgery to Chemotherapy Improves the Overall Survival Rate for Patients with Metastatic Head & Neck Cancer.
Chemotherapy is a well established treatment for metastases, with high response rates, remission and longer survival.
Adding CyberKnife Radiosurgery is especially effective because it delivers high doses of radiation directly to the tumor, greatly reducing the risk of damage to healthy surrouding tissue.
The 2-year over all survival rate was 76.4% in the combined therapy group compared to 54.5% in the chemotherapy-alone group.
The lead researcher, Dr. Melvin Chua says, “The combined treatment resulted in a 58% reduction in the risk for death.This study has defined a new standard of care for patients with metastatic head and neck cancer. These patients are treated with first-line chemotherapy and if patients achieve a response to chemo after three to four cycles, high-dose local radiotherapy to the primary tumor should be offered as a standard of care.”
The research was Published in the medical journal JAMA Oncology.
At CyberKnife Miami we have good success treating head and neck cancers and are among the few CyberKnife centers that treat the disease, whether it’s metastatic or not.
Talk to our cancer experts to find out if you are a candidate for this noninvasive cancer treatment.
Call 305-279-2900 & go to our website now to learn more.